HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kosei Yasumoto Selected Research
Kosei Yasumoto Research Topics
Disease
59
Neoplasms (Cancer)
11/2020 - 01/2002
41
Lung Neoplasms (Lung Cancer)
11/2020 - 03/2002
27
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2011 - 01/2002
11
Neoplasm Metastasis (Metastasis)
08/2020 - 06/2002
10
Adenocarcinoma
10/2011 - 09/2005
8
Adenocarcinoma of Lung
11/2020 - 05/2006
8
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2011 - 09/2005
6
Carcinoma (Carcinomatosis)
01/2009 - 04/2003
5
Colorectal Neoplasms (Colorectal Cancer)
08/2020 - 06/2002
4
Melanoma (Melanoma, Malignant)
09/2009 - 07/2002
3
Neoplasm Micrometastasis
12/2010 - 01/2002
3
Lymphatic Metastasis
08/2009 - 10/2006
3
Large Cell Carcinoma
03/2007 - 09/2005
3
Esophageal Neoplasms (Esophageal Cancer)
09/2005 - 05/2005
2
Testicular Neoplasms (Testicular Cancer)
01/2018 - 04/2010
2
Fistula
09/2011 - 08/2010
2
Myasthenia Gravis
09/2010 - 01/2009
2
Malignant Mesothelioma
07/2010 - 07/2009
2
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2009 - 09/2007
2
Esophageal Squamous Cell Carcinoma
05/2009 - 07/2007
2
Carcinogenesis
05/2006 - 07/2005
2
Disease Progression
12/2005 - 01/2005
1
Endometrial Neoplasms (Endometrial Cancer)
08/2020
1
Neuroendocrine Carcinoma
08/2020
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2020
1
Uterine Neoplasms (Uterine Cancer)
08/2020
1
Colonic Neoplasms (Colon Cancer)
04/2011
1
Hyperthermia
03/2011
Drug/Important Bio-Agent (IBA)
18
Antigens
IBA
11/2020 - 03/2002
12
ErbB Receptors (EGF Receptor)
IBA
12/2011 - 01/2006
12
Proteins (Proteins, Gene)
FDA Link
12/2010 - 01/2002
8
Gefitinib (Iressa)
FDA Link
11/2010 - 01/2006
8
Neoplasm Antigens (Tumor Antigens)
IBA
01/2010 - 03/2002
6
Peptides (Polypeptides)
IBA
11/2020 - 04/2004
6
Paraffin
IBA
12/2010 - 10/2004
5
Immunoglobulin G (IgG)
IBA
07/2010 - 03/2002
5
Cytochrome P-450 Enzyme System (Cytochrome P450)
IBA
05/2008 - 03/2003
4
Tyrosine Kinase Inhibitors
IBA
12/2011 - 12/2006
4
Messenger RNA (mRNA)
IBA
04/2011 - 08/2002
4
Cisplatin (Platino)
FDA Link
Generic
11/2010 - 08/2002
4
Biological Products
IBA
08/2009 - 03/2005
3
Asbestos
IBA
07/2010 - 04/2003
3
Indicators and Reagents (Reagents)
IBA
05/2009 - 12/2004
3
Estrogens (Estrogen)
FDA Link
01/2009 - 07/2007
3
Cytokines
IBA
12/2007 - 02/2002
3
Cytochromes
IBA
05/2007 - 12/2002
3
HLA-A24 Antigen
IBA
03/2007 - 05/2005
3
Cytochrome P-450 CYP2E1 (CYP2E1)
IBA
01/2007 - 12/2002
3
Tumor Biomarkers (Tumor Markers)
IBA
03/2005 - 01/2003
3
Keratins (Keratin)
IBA
07/2003 - 01/2002
2
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
12/2011 - 05/2010
2
Estrogen Receptor beta
IBA
03/2011 - 01/2009
2
Estrogen Receptors
IBA
03/2011 - 01/2009
2
Biomarkers (Surrogate Marker)
IBA
03/2011 - 07/2010
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2010 - 07/2007
2
Paclitaxel (Taxol)
FDA Link
Generic
11/2010 - 07/2010
2
Carboplatin (JM8)
FDA Link
Generic
11/2010 - 07/2010
2
HLA Antigens (Human Leukocyte Antigens)
IBA
10/2010 - 11/2007
2
HLA-A Antigens (HLA-A)
IBA
01/2010 - 03/2007
2
Vaccines
IBA
09/2009 - 05/2005
2
Antibodies
IBA
07/2009 - 03/2002
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2009 - 01/2006
2
Aromatase (CYP19)
IBA
01/2009 - 05/2008
2
Enzymes
IBA
05/2008 - 02/2002
2
Transcription Factors (Transcription Factor)
IBA
12/2007 - 11/2004
2
Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
IBA
05/2007 - 01/2007
2
Cytochrome P-450 CYP1A1 (CYP1A1)
IBA
01/2007 - 03/2003
2
Cytochrome P-450 CYP3A
IBA
01/2007 - 05/2005
2
Carcinoembryonic Antigen
IBA
10/2006 - 03/2005
2
Complementary DNA (cDNA)
IBA
09/2006 - 03/2002
2
Histidine (L-Histidine)
FDA Link
05/2006 - 05/2006
2
Phytohemagglutinins
IBA
05/2006 - 07/2005
2
Amino Acids
FDA Link
05/2006 - 04/2004
1
HLA-B15 Antigen
IBA
11/2020
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
02/2012
1
antigen CYFRA21.1
IBA
10/2011
1
Fibrin Tissue Adhesive (Fibrin Sealant)
IBA
09/2011
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
04/2011
1
Therapeutic Uses
IBA
03/2011
1
Cadherins (E-Cadherin)
IBA
12/2010
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2010
1
Vascular Endothelial Growth Factor C
IBA
12/2010
1
alpha Catenin (alpha E-Catenin)
IBA
12/2010
1
gamma Catenin (Plakoglobin)
IBA
12/2010
1
beta Catenin
IBA
12/2010
1
Gemcitabine
FDA Link
11/2010
Therapy/Procedure
11
Immunotherapy
01/2020 - 07/2002
9
Therapeutics
08/2020 - 06/2002
7
Drug Therapy (Chemotherapy)
08/2020 - 05/2005
4
Adjuvant Chemotherapy
01/2013 - 03/2010
3
Cell- and Tissue-Based Therapy (Cell Therapy)
08/2020 - 08/2020
3
Radiotherapy
03/2011 - 01/2009
2
Heterologous Transplantation (Xenotransplantation)
11/2020 - 07/2009
2
Segmental Mastectomy (Lumpectomy)
01/2013 - 01/2011
2
Ligation
08/2010 - 05/2008
2
Lymph Node Excision (Lymph Node Dissection)
03/2010 - 06/2002
1
Hepatectomy
01/2017
1
Conservative Treatment
09/2011
1
Thoracotomy
04/2011
1
Aftercare (After-Treatment)
03/2011